StonvexLoading…
StonvexStonvexStonvexCore line items from LLYVA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q1 2025 2025-03-31 |
|---|---|---|---|---|
Revenue | $63.62M | $381.95M | $247.39M | $47.06M |
Operating Income | $-16.69M | $-51.73M | $-36.72M | $-17.28M |
Net Income | $-294.14M | $-86.97M | $-265.53M | $-29.48M |
EPS (Diluted) | $-3.20 | Not available | Not available | $-0.32 |
Total Assets | $1.88B | $1.89B | $1.88B | Not available |
Total Liabilities | $2.18B | $1.92B | $2.26B | Not available |
Cash & Equivalents | $524.43M | $545.49M | $375.84M | Not available |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 92.50M | 92.47M | Not available | Not available |